Go to the list of all blogs
John Y White's Avatar
published in Blogs
Oct 14, 2026
TickeronGET DAILY SIGNALS
FBGL vs NIVF: Micro-Caps Facing Compliance Challenges After Reverse Splits

FBGL vs NIVF: Micro-Caps Facing Compliance Challenges After Reverse Splits

Key Takeaways

  • FBGL (FBS Global) is a Singapore-based green building and interior fit-out contractor, while NIVF (NewGenIvf Group) is an assisted-reproduction and fertility-services provider across Southeast Asia.
  • Both are Nasdaq Capital Market micro-caps that recently relied on reverse stock splits to address exchange listing requirements.
  • FBGL regained Nasdaq minimum bid price compliance, whereas NIVF has traded near historic lows amid repeated dilution and multiple reverse splits.
  • FBGL has declined roughly 47% over the past year, while NIVF has fallen more than 99% over the same period.
  • Neither name currently demonstrates positive operating momentum, making this a comparison of turnaround potential against elevated risk.

Introduction

Investors scanning the Nasdaq Capital Market for contrarian or turnaround ideas frequently run into small, deeply discounted names where the risks often outweigh the potential rewards. This comparison looks at two such companies: FBGL, a Singapore-based construction and building-services operator, and NIVF, a fertility-services group that has branched into other areas. Although they operate in completely different sectors, both have dealt with reverse stock splits, compliance issues, and steep price drops in recent weeks.

FBGL Overview and Recent Performance

FBS Global Limited, trading as FBGL, is a Singapore-based building contractor and interior fit-out specialist that works on institutional, residential, commercial, and industrial projects. The company also supplies building materials and precast concrete components and offers construction, waste-recycling, and pavement consultancy services. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Recent trading has been influenced by listing-compliance steps. FBS Global carried out a 1-for-10 share consolidation in late September 2026 and later confirmed it had met Nasdaq’s minimum bid price requirement, closing the prior deficiency. Even so, FBGL has declined roughly 47% over the trailing 52 weeks and trades below its 50-day and 200-day moving averages. The company shows negative return on equity and negative operating cash flow, which have pressured sentiment despite a relatively modest debt load compared with book value.

NIVF Overview and Recent Performance

NewGenIvf Group Limited, trading as NIVF, offers assisted-reproduction services including in vitro fertilization through clinics in Thailand, Cambodia, Hong Kong, and Kyrgyzstan. The company has also outlined plans in real estate development and digital-asset ventures, including a stake in an artificial-intelligence-related entity. From what I see, the business model has broadened beyond its core healthcare focus.

Market activity has featured notable volatility and ongoing share issuance. The company completed a 1-for-4 reverse stock split in March 2026 and recently priced a public offering that added to dilution. Trading halts and repeated equity raises have accompanied a decline exceeding 99% over the past 52 weeks, leaving the share price near historic lows. Institutional ownership remains minimal, and the stock shows very large trading-volume swings typical of a speculative, event-driven profile.

Head-to-Head Comparison

The two companies differ markedly in business model and risk profile. FBGL runs a focused, revenue-generating construction business with a clear sector identity and has restored exchange compliance, giving it a more defined operating base. NIVF combines a fertility-services core with newer digital-asset and real-estate ambitions, which widens the opportunity set but also spreads strategic focus thinner.

On momentum, FBGL has seen a sizable yet comparatively contained drawdown, while NIVF has experienced near-total value erosion along with repeated share issuance and multiple reverse splits. Sector exposure varies as well: FBGL is linked to construction and infrastructure demand, whereas NIVF operates in healthcare with an added layer of speculative activity. Both carry liquidity, governance, and execution risks common to micro-cap listings, though the scale and nature of those risks appear materially higher for NIVF.

Tickeron AI Verdict

Based on factors such as trend consistency, capital-structure stability, and catalyst clarity, Tickeron’s AI would likely favor FBGL in the current environment. The company’s restored listing compliance and more contained drawdown point to comparatively stronger positioning, while NIVF’s ongoing dilution and extreme volatility create a less stable risk-reward profile. This view is probabilistic rather than certain, and both stocks merit close monitoring given their speculative micro-cap traits.

Exploring AI Trading Bots for Micro-Cap Monitoring

I’ve found Tickeron’s AI Trading Bots helpful when tracking names like these. The platform offers a range of automated strategies with different timeframes and risk parameters, letting users review performance statistics and see which approaches align with specific objectives. In my experience, reviewing the available metrics can surface ideas worth further research without replacing individual due diligence.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: NIVF, FBGL

Contributor

John Y White's AvatarJohn Y White|Beginner

Experienced trader focused on market analysis, identifying trading opportunities, and developing custom trading signals based on market trends, price action, and data-driven insights. Join my Trader Club to follow my latest analysis, trading ideas, and active signals: https://tickeron.com/app/trader-club/103/view?tab=active&section=trades&via=john


NIVF in -84.22% downward trend, falling for three consecutive days on November 20, 2026

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where NIVF declined for three days, in 237 of 241 cases, the price declined further within the following month. The odds of a continued downward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Aroon Indicator for NIVF entered a downward trend on November 20, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 22 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is 16 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 37 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.041) is normal, around the industry mean (204.532). P/E Ratio (0.000) is within average values for comparable stocks, (21.572). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.498). Dividend Yield (0.000) settles around the average of (0.153) among similar stocks. P/S Ratio (0.005) is also within normal values, averaging (2.688).

The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 99 (best 1 - 100 worst), indicating slightly worse than average price growth. NIVF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NIVF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.

Notable companies

The most notable companies in this group are DaVita (NYSE:DVA), Community Health Systems (NYSE:CYH), WW International Inc (NASDAQ:WW).

Industry description

Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.

Market Cap

The average market capitalization across the Hospital/Nursing Management Industry is 5.37B. The market cap for tickers in the group ranges from 20.9K to 107.17B. HCA holds the highest valuation in this group at 107.17B. The lowest valued company is NMMCF at 20.9K.

High and low price notable news

The average weekly price growth across all stocks in the Hospital/Nursing Management Industry was -12%. For the same Industry, the average monthly price growth was -12%, and the average quarterly price growth was 0%. CHE experienced the highest price growth at 0%, while NIVF experienced the biggest fall at -88%.

Volume

The average weekly volume growth across all stocks in the Hospital/Nursing Management Industry was 13%. For the same stocks of the Industry, the average monthly volume growth was 102% and the average quarterly volume growth was 58%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 49
Price Growth Rating: 59
SMR Rating: 66
Profit Risk Rating: 83
Seasonality Score: -4 (-100 ... +100)
Real Time Patterns 3
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry HospitalNursingManagement

Industry
N/A
Address
Sukhumvit 21 Road, Asoke
Phone
N/A
Employees
87
Web
https://www.nivf.global
Interact to see
Advertisement
The ADR gapped lower in premarket trading and was at $335.71 in early regular-session trading, -4.65% from Thursday's close of $352.09. The move extends a global AI and chip unwind: investors are cutting crowded semiconductor bets on stretched valuations, rising sector debt, data-center opposition and Nvidia's leadership turmoil, and Nvidia's strong quarter failed to calm sentiment.
Micron shares slid from Thursday's $690.44 close to $635.41, a -7.97% loss, deepening during Friday's regular session after an already soft premarket. The decline was sector-driven, not company-specific: investors kept unwinding AI exposure as Anthropic fell back after its debut, while hawkish Fed comments and doubts about Nvidia's leadership and AI spending returns pressured chip valuations.
Meta Platforms fell from a $596.22 previous close to $583.40, a -2.15% move, with the decline built in premarket trading and held through early Friday action after Thursday's -3.27% drop. The drop was sector-driven, not company-specific: Anthropic slid roughly -6% to -10% premarket on its second trading day, reviving doubts that AI spending will generate returns, and AI-linked megacaps sold off broadly with Nasdaq 100 futures down about -1.5%.
ANT dropped from Thursday's record-debut close of $97.17 to about $88.56 in Friday premarket trading, a -8.86% move ahead of the opening bell, still above its $83 IPO price. The decline came from a broad AI and technology selloff rather than any Anthropic-specific disclosure: Nvidia and AMD traded lower premarket, index futures were sharply down, and renewed doubts over AI spending and valuations drove profit-taking after the +17.07% first-day gain.
IREN dropped -8.33% to $13.21 from Thursday's $14.41 close, with weakness building in premarket and extending through the first hour of regular trading. The decline extends a sector-wide neocloud rout: Anthropic's post-IPO slide and turmoil at Nvidia revived doubts about debt-funded AI data center spending, dragging CoreWeave and Nebius down with it; no IREN-specific news was released.
FBGL vs NIVF: Micro-Caps Facing Compliance Challenges After Reverse Splits